Back
4D Molecular Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
FDMT
Sponsored
Zero Day Options Trade LIVE Tuesday at 2 p.m. ET!
Discover The Zero Day Loophole (BEFORE Tues at 2 p.m. ET!)
Buy
51
FDMT
4D Molecular Therapeutics
Last Price:
6.90
Seasonality Move:
19.19%
7 Day Trial
ALL ACCESS PASS
$
7
Better Than Oil Stocks
CLICK HERE TO FIND OUT MORE4D Molecular Therapeutics Price Quote
$6.90
-0.34 (-4.7%)
(Updated: December 11, 2024 at 5:55 PM ET)
4D Molecular Therapeutics Key Stats
Buy
51
4D Molecular Therapeutics (FDMT)
is a Buy
Day range:
$6.99 - $7.33
52-week range:
$6.77 - $36.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
21,611.02
P/B ratio:
0.61%
Volume:
461K
Avg. volume:
770.9K
1-year change:
-51.54%
Market cap:
$334.7M
Revenue:
$20.7M
EPS:
$-2.85
How Much Does 4D Molecular Therapeutics Make?
-
How Much Are 4D Molecular Therapeutics's Sales Annually?
FDMT Revenues are $20.7M -
How Much Profit Does 4D Molecular Therapeutics's Make A Year?
FDMT net income is -$100.8M
Is 4D Molecular Therapeutics Growing As A Company?
-
What Is 4D Molecular Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is -1% -
What Is 4D Molecular Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
4D Molecular Therapeutics Stock Price Performance
-
Did 4D Molecular Therapeutics Stock Go Up Last Month?
4D Molecular Therapeutics share price went down by -10.84% last month -
Did FDMT's Share Price Rise Over The Last Year?
FDMT share price fell by -51.54% over the past 1 year
What Is 4D Molecular Therapeutics 52-Week High & Low?
-
What Is 4D Molecular Therapeutics’s 52-Week High Share Price?
4D Molecular Therapeutics has traded as high as $36.25 over the past 52 weeks -
What Is 4D Molecular Therapeutics’s 52-Week Low Share Price?
4D Molecular Therapeutics has traded as low as $6.77 over the past 52 weeks
4D Molecular Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy 4D Molecular Therapeutics?
-
How Much Debt Does 4D Molecular Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does 4D Molecular Therapeutics Have?
Cash and short term investments quarterly total is $501.9M -
What Is 4D Molecular Therapeutics’s Book Value Per Share?
Book value per share is 10.63
Is 4D Molecular Therapeutics Cash Flow Positive?
-
What Is FDMT Cash Flow From Operations?
Cash flow from operations (TTM) is -$113.4M -
What Is 4D Molecular Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $341.4M -
What Is 4D Molecular Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$316.2M
4D Molecular Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
FDMT return on invested capital is -30.15% -
What Is 4D Molecular Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -28.07% -
What Is FDMT Return On Equity?
ROE is a measure of profitability and is -30.15%
4D Molecular Therapeutics Earnings Date & Stock Price
-
What Is 4D Molecular Therapeutics's Stock Price Today?
A single share of FDMT can be purchased today for 7.24 -
What Is 4D Molecular Therapeutics’s Stock Symbol?
4D Molecular Therapeutics trades on the nasdaq under the ticker symbol: FDMT -
When Is 4D Molecular Therapeutics’s Next Earnings Date?
The next quarterly earnings date for 4D Molecular Therapeutics is scheduled on February 28, 2025 -
When Is FDMT's next ex-dividend date?
4D Molecular Therapeutics's next ex-dividend date is December 12, 2024 -
How To Buy 4D Molecular Therapeutics Stock?
You can buy 4D Molecular Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
4D Molecular Therapeutics Competitors
-
Who Are 4D Molecular Therapeutics's Competitors?
Below is a list of companies who compete with 4D Molecular Therapeutics or are related in some way:
4D Molecular Therapeutics Dividend Yield
-
What Is FDMT Dividend Yield?
4D Molecular Therapeutics’s dividend yield currently is 0% -
What Is 4D Molecular Therapeutics’s Payout Ratio?
4D Molecular Therapeutics’s payout ratio is 0% -
When Did 4D Molecular Therapeutics Last Pay A Dividend?
The latest dividend pay date is December 12, 2024 -
What Is 4D Molecular Therapeutics’s Dividend Per Share?
4D Molecular Therapeutics pays a dividend of $0.00 per share
4D Molecular Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -12.16% |
Revenue: | -99.99% | -99.5% |
Analyst Recommendations
Buy Recommendations: | 5 |
---|---|
Hold Recommendations: | 1 |
Sell Recommendations: | 1 |
Price Target: | 45.64 |
Upside from Last Price: | 530.34% |